Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. Early life. Collis was born in South Africa and attended the University of Witwatersrand, where he earned a Bachelor of Commerce. Collis is Jewish. Career
AmerisourceBergen now expects 2023 adjusted earnings in the range of $11.85 to $11.95 per share, compared with its prior forecast of $11.70 to $11.90 per share. Analysts were expecting an annual ...
Walgreens said in a statement it would use the proceeds to pay down debt and for general corporate purposes. The latest share sale includes $250 million that drug distributor AmerisourceBergen ...
What AmerisourceBergen Does With Its Cash. In the quest to find great investments, most investors focus on earnings to gauge a company's financial strength. This is a good start, but earnings can ...
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
Howell was most recently Senior Vice President, Business Development, AmerisourceBergen Corporation and President of AmerisourceBergen Consulting Services, a business unit of the Company.
Michael Dennis DiCandilo (born 1961) is an American businessman who was chief financial officer and executive vice president of AmerisourceBergen Corporation. He served as CFO from 2002 to February 2012. and won the 2011 Institutional Investor Best CFO Award in Healthcare Distribution and Technology.